Transformation of follicular lymphoma to diffuse large cell lymphoma is associated with a heterogeneous set of DNA copy number and gene expression alterations

Blood

Volumn 101, Issue 8, 2003, Pages 3109-3117

  Martinez Climent, Jose A ^a   Alizadeh, Ash A ^b   Segraves, Richard ^b   Blesa, David ^b   Rubio Moscardo, Fanny ^b   Albertson, Donna G ^b   Garcia Conde, Javier ^b   Dyer, Martin J S ^b   Levy, Ronald ^b   Pinkel, Daniel ^b   Lossos, Izidore S ^b  

^a UNIVERSITY OF VALENCIA   (Spain)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CHROMOSOME ABERRATION; CHROMOSOME DELETION; CHROMOSOME GAIN; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; DISEASE COURSE; DNA MICROARRAY; FOLLICULAR LYMPHOMA; GENE AMPLIFICATION; GENE DELETION; GENE EXPRESSION; GENE LOCUS; GENE NUMBER; GENE TARGETING; GENETIC ANALYSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; LARGE CELL LYMPHOMA; MALIGNANT TRANSFORMATION; PATHOGENESIS; PRIORITY JOURNAL; ALLELIC IMBALANCE; CELL TRANSFORMATION; COMPARATIVE STUDY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; HUMAN CHROMOSOME; PATHOLOGY; ULTRASTRUCTURE;

COMPLEMENTARY DNA; DNA;

ALLELIC IMBALANCE; CELL TRANSFORMATION, NEOPLASTIC; CHROMOSOME ABERRATIONS; CHROMOSOME DELETION; CHROMOSOMES, HUMAN; DISEASE PROGRESSION; DNA, COMPLEMENTARY; DNA, NEOPLASM; GENE AMPLIFICATION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LYMPHOMA, FOLLICULAR; LYMPHOMA, LARGE-CELL, DIFFUSE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS;

EID: 0038724269     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2002-07-2119     Document Type: Article

References (47)

1. Harris NL, Jaffe ES, Stein H, et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood. 1994;84;1361-1392.
2. Bastion Y, Sebban C, Berger F, et al. Incidence, predictive factors, and outcome of lymphoma transformation in follicular lymphoma patients. J Clin Oncol. 1997;15:1587-1594.
3. Horning SJ, Rosenberg SA. The natural history of initially untreated low-grade non-Hodgkin's lymphomas. N Engl J Med. 1984;311:1471-1475.
4. Lee JT, Innes DJ Jr, Williams ME. Sequential bcl-2 and c-myc oncogene rearrangements associated with the clinical transformation of non-Hodgkin's lymphoma. J Clin Invest. 1989;84:1454-1459.
5. Lo Coco F, Galdano G, Louie DC, Offit K, Chaganti RS, Dalla-Favera R. p53 mutations are associated with histologic transformation of follicular lymphoma. Blood. 1993;82:2289-2295.
6. Sander CA, Yano T, Clark HM, et al. p53 mutation is associated with progression in follicular lymphomas. Blood. 1993;82:1994-2004.
7. Matolcsy A, Casali P, Warnke RA, Knowles DM. Morphologic transformation of follicular lymphoma is associated with somatic mutation of the translocated Bcl-2 gene. Blood. 1996;88:3937-3944.
8. Lossos IS, Levy R. Higher-grade transformation of follicle center lymphoma is associated with somatic mutation of the 5′ noncoding regulatory region of the BCL-6 gene. Blood. 2000;96:635-639.
9. Pinyol M, Cobo F, Bea S, et al. p16(INK4a) gene inactivation by deletions, mutations, and hypermethylation is associated with transformed and aggressive variants of non-Hodgkin's lymphomas. Blood. 1998;91:2977-2984.
10. Yunis JJ, Frizzera G, Oken MM, McKenna J, Theologides A, Arnesen M. Multiple recurrent genomic defects in follicular lymphoma: a possible model for cancer. N Engl J Med. 1987;316:79-84.
11. Offit K, Chaganti RSK. Chromosomal aberrations in non-Hodgkin's lymphoma: biological and clinical correlations. Hematol Oncol Clin North Am. 1991;5:853-869.
12. Tilly H, Rossi A, Stamatoullas A, et al. Prognostic value of Chromosomal abnormalities in follicular lymphoma. Blood. 1994;84:1043-1049.
13. Horsman DE, Connors JM, Pantzar T, Gascoyne RD. Analysis of secondary chromosomal alterations in 165 cases of follicular lymphoma with t(14;18). Genes Chromosomes Cancer. 2001;30:375-382.
14. Kallioniemi A, Kallioniemi OP, Sudar D, et al. Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science. 1992;258:818-821.
15. Bentz M, Werner CA, Dohner H, et al. High incidence of chromosomal imbalances and gene amplifications in the classical follicular variant of follicle center lymphoma. Blood. 1996;88:1437-1444.
16. Avet-Loiseau H, Vigier M, Moreau A, et al. Comparative genomic hybridization detects genomic abnormalities in 80% of follicular lymphomas. Br J Haematol. 1997;97:119-122.
17. Hough RE, Goepel JR, Alcock HE, Hancock BW, Lorigan PC, Hammond DW. Copy number gain at 12q12-14 may be important in the transformation from follicular lymphoma to diffuse large B cell lymphoma. Br J Cancer. 2001;84:499-503.
18. Viardot A, Martin-Subero JI, Siebert R, et al. Detection of secondary genetic aberrations in follicle center cell derived lymphomas: assessment of the reliability of comparative genomic hybridization and standard chromosome analysis. Leukemia. 2001;15:177-183.
19. Goff LK, Neat MJ, Crawley CR, et al. The use of real-time quantitative polymerase chain reaction and comparative genomic hybridization to identify amplification of the REL gene in follicular lymphoma. Br J Haematol. 2000;111:618-625.
20. Lossos IS, Alizadeh AA, Diehn M, et al. Transformation of follicular lymphoma to diffuse large-cell lymphoma: alternative patterns with increased or decreased expression of c-myc and its regulated genes. Proc Natl Acad Sci U S A. 2002;99:8886-8891.
21. Snijders AM, Nowak N, Segraves R, et al. Assembly of microarrays for genome-wide measurement of DNA copy number. Nat Genet. 2001;29:263-264.
22. Jain AN, Tokuyasu TA, Snijders AM, Segraves R, Albertson DG, Pinkel D. Fully automatic quantification of microarray image data. Genome Res. 2002;12:325-332.
23. Sanchez-Izquierdo D, Siebert R, Harder L, et al. Detection of translocations affecting the BCL6 locus in B cell non-Hodgkin's lymphoma by interphase fluorescence in situ hybridization. Leukemia. 2001;15:1475-1484.
24. Mehra S, Messner H, Minden M, Chaganti RSK. Molecular cytogenetic characterization of non-Hodgkin lymphoma cell lines. Genes Chrom Cancer. 2002;33:225-234.
25. Nagai M, Fujita M, Ohmori M. et al. Establishment of a novel human B-cell line (OZ) with t(14; 18)(q32;q21) and aberrant p53 expression was associated with the homozygous deletions of p15 and p16 genes. Hematol Oncol. 1997;15:109-119.
26. Hijikata M, Kato N, Sato T, Shimotohno K. Molecular cloning and characterization of a cDNA for a novel phorbol-12-myristate-13-acetate-responsive gene that is highly expressed in an adult T-cell leukemia cell line. J Virol. 1990;64:4632-4639.
27. Alizadeh AA, Eisen MB, Davis RE, et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature. 2000;403:503-511.
28. Pinkel D, Segraves R, Sudar D, et al. High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays. Nat Genet. 1998;20:207-211.
29. Nagy M, Balazs M, Adam Z, et al. Genetic instability is associated with follicle center lymphoma. Leukemia. 2000;2142-2148.
30. Houldsworth J, Mathew S, Rao PH, et al. REL prpto-oncogene is frequently amplified in extranodal diffuse large cell lymphoma. Blood. 1996;87:25-29.
31. Rao PH, Houldsworth J, Dyomina K, et al. Chromosomal and gene amplification in diffuse large B-cell lymphoma. Blood. 1998;92;234-240.
32. Joos S, Otano-Joos MI, Ziegler S, et al. Primary mediastinal (thymic) B-ceil lymphoma is characterized by gains of chromosomal material including 9p and amplification of the REL gene. Blood. 1996;87:1571-1578.
33. Martin-Zubero J, Gesk S, Harder L, et al. Recurrent involvement of the REL and BCL11A loci in classical Hodgkin lymphoma. Blood. 2002;99:1474-1477.
34. Saterwhite E, Sonoki T, Willis TG, et al. The BCL11 gene family: involvement of BCL11A in lymphoid malignancies. Blood. 2001;98:3413-3420.
35. Merup M, Juliusson G, Wu X, et al. Amplification of multiple regions of chromosome 12, including 12q13-15, in chronic lymphocytic leukaemia. Eur J Haematol. 1997;58:174-180.
36. Dierlamm J, Wlodarska I, Michaux L, et al. FISH identifies different types of duplications with 12q13-15 as the commonly involved segment in B-cell lymphoproliferative malignancies characterized by partial trisomy 12. Genes Chromosomes Cancer. 1997;20:155-166.
37. Bea S, Ribas M, Hernandez JM, et al. Increased number of chromosomal imbalances and high-level DNA amplifications in mantle cell lymphoma are associated with blastoid variants. Blood. 1999;93:4365-4374.
38. Delmer A, Ajchenbaum-Cymbalista F, Tang R, et al. Overexpression of cyclin D2 in chronic B-cell malignancies. Blood. 1995;85:2870-2876.
39. Sinclair AM, Lee JA, Goldstein A, et al. Lymphoid apoptosis and myeloid hyperplasia in CCAAT displacement protein mutant mice. Blood. 2001;98:3658-3567.
40. Akasaka H, Akasaka T, Kurata M, et al: Molecular anatomy of BCL6 translocations revealed by long-distance polymerase chain reaction-based assays. Cancer Res. 2000;60:2335-2341.
41. Sonoki T, Harder L, Horsman DE, et al. Cyclin D3 is a target gene of t(6;14)(p21.1;q32.3) of mature B-cell malignancies. Blood. 2001;98:2837-2844.
42. Bentz M, Barth TF, Bruderlein S, et al. Gain of chromosome arm 9p is characteristic of primary mediastinal B-cell lymphoma (MBL): comprehensive molecular cytogenetic analysis and presentation of a novel MBL cell line. Genes Chromosomes Cancer. 2001;30:393-401.
43. Joos S, Menz CK, Wrobel G, et al. Classical Hodgkin lymphoma is characterized by recurrent copy number gains of the short arm of chromosome 2. Blood. 2002;99:1381-1387.
44. Leary JA, Kerr J, Chenevix-Trench G, et al. Increased expression of the NME1 gene is associated with metastasis in epithelial ovarian cancer. Int J Cancer. 1995;64:189-195.
45. Bullrich F, Rasio D, Kitada S, et al. ATM gene mutations in B-cell chronic lymphocytic leukemia. Cancer Res. 1999;59:24-27.
46. Schaffner C, Idler I, Stilgenbauer S, Dohner H, Lichter P. Mantle cell lymphoma is characterized by inactivation of the ATM gene. Proc Natl Acad Sci U S A. 2000;97:2773-2778.
47. Herranz M, Urioste M, Santos J, et al. Allelic losses and genetic instabilities of PTEN and p73 in non-Hodgkin lymphomas. Leukemia. 2000;14:1325-1327.